Hangzhou Wensli Silk Culture
301066
Yoantion Industrial Inc.,
301053
Xinlei Compressor
301317
4
QIFENG
873169
5
LAISAI LASER
871263
CN Stock MarketDetailed Quotes
603456 Zhejiang Jiuzhou Pharmaceutical
- 13.83
- -0.08-0.58%
Market Closed May 9 15:00 CST
12.38BMarket Cap19.99P/E (TTM)
13.93High13.79Low75.19KlotVolume13.93Open13.91Pre Close104.09MTurnover0.84%Turnover Ratio20.43P/E (Static)895.24MShares18.4152wk High1.41P/B12.38BFloat Cap11.8352wk Low15.30Limit Up895.24MShs Float61.86Historical High12.52Limit Down1.01%Amplitude3.09Historical Low0.50Dividend TTM13.84Avg Price46.81KlotAsk3.62%Div YieldTTM100Lot Size27.39KlotBid
Zhejiang Jiuzhou Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.98%1.49B | -6.57%5.16B | -13.36%3.97B | -15.07%2.76B | -15.73%1.48B | 1.44%5.52B | 4.66%4.58B | 10.16%3.25B | 27.49%1.75B | 34.01%5.45B |
| Operating revenue | 0.98%1.49B | -6.57%5.16B | -13.36%3.97B | -15.07%2.76B | -15.73%1.48B | 1.44%5.52B | 4.66%4.58B | 10.16%3.25B | 27.49%1.75B | 34.01%5.45B |
| Other operating revenue | ---- | -36.86%74.24M | ---- | -23.64%30.06M | ---- | -55.51%117.58M | ---- | -70.31%39.37M | ---- | 9.89%264.29M |
| Total operating cost | -1.16%1.15B | -1.12%4.23B | -6.77%3.19B | -11.98%2.18B | -13.79%1.17B | -0.13%4.28B | -0.51%3.42B | 5.51%2.47B | 21.45%1.36B | 28.48%4.28B |
| Operating cost | -4.18%932.61M | -0.76%3.42B | -6.85%2.59B | -10.67%1.79B | -11.92%973.34M | -3.21%3.44B | -2.70%2.78B | 4.60%2B | 24.46%1.11B | 31.33%3.56B |
| Operating tax surcharges | 0.75%20.52M | 13.72%55.95M | 23.92%40.09M | 50.40%31.78M | 70.02%20.37M | 37.56%49.2M | 33.79%32.35M | 36.68%21.13M | 53.89%11.98M | 34.87%35.77M |
| Operating expense | 13.83%22.94M | 21.80%99.9M | 11.03%72.34M | -2.01%43.89M | -12.01%20.16M | 42.63%82.02M | 27.09%65.16M | 15.76%44.79M | 15.67%22.91M | 17.43%57.5M |
| Administration expense | 6.42%115.29M | -6.32%417.73M | -17.45%300.56M | -25.92%197.95M | -15.67%108.34M | 3.91%445.93M | -3.01%364.07M | 1.75%267.19M | 3.96%128.47M | 27.22%429.15M |
| Financial expense | 76.43%-4.45M | -2.93%-77.85M | 12.09%-49.71M | -50.74%-47.61M | -339.58%-18.89M | 12.22%-75.63M | 39.19%-56.55M | 43.76%-31.58M | -37.02%7.88M | -331.67%-86.17M |
| -Interest expense (Financial expense) | -70.49%2.38M | -10.84%19.38M | -9.95%16.31M | 31.20%14.23M | 73.84%8.07M | -2.87%21.73M | -6.15%18.11M | -27.04%10.85M | -43.63%4.64M | -10.02%22.38M |
| -Interest Income (Financial expense) | 76.85%-6.12M | 6.27%-86.06M | -13.43%-72.83M | -93.28%-57.72M | -337.67%-26.45M | -595.42%-91.82M | -672.55%-64.21M | -566.91%-29.86M | -537.82%-6.04M | -72.06%-13.2M |
| Research and development | 4.33%67.68M | -4.81%314.91M | 0.13%240.14M | -4.20%160.01M | -17.64%64.87M | 15.12%330.83M | 5.46%239.84M | 0.14%167.03M | 22.71%78.77M | 65.77%287.38M |
| Credit Impairment Loss | 92.45%-2.56M | 17.57%-16.63M | 48.14%-12.93M | -27.53%-21.98M | -107.86%-33.97M | -475.45%-20.17M | -567.98%-24.94M | -41.10%-17.24M | -11,421.39%-16.34M | 165.38%5.37M |
| Asset Impairment Loss | -25,039.17%-27.2M | -179.38%-218.48M | 26.65%-38.63M | 49.80%-26.27M | 99.71%-108.21K | -31.82%-78.2M | -18.41%-52.66M | -19.56%-52.33M | -82.19%-37.01M | -16.76%-59.33M |
| Other net revenue | 11.68%-24.27M | -179.32%-200.59M | 59.90%-27.37M | 50.76%-32.68M | 41.13%-27.48M | -28.83%-71.81M | -15.88%-68.27M | -21.53%-66.37M | -981.54%-46.67M | -343.52%-55.74M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | 108.65%5.17M | 102.20%576.41K | 365.00%7.13M | -2,433.50%-35.22M |
| Invest income | 58.04%-982.57K | 58.00%-8.13M | 79.62%-4.63M | 65.48%-5.33M | 64.06%-2.34M | -1,035.48%-19.36M | -212.02%-22.72M | -197.83%-15.44M | -148.89%-6.52M | -96.61%2.07M |
| -Including: Investment income associates | 47.61%-1.23M | -54.14%-11.96M | -61.88%-8.29M | -63.54%-5.33M | -43.86%-2.34M | -13,271.24%-7.76M | -3,321.17%-5.12M | -2,336.18%-3.26M | -495.82%-1.63M | -95.09%58.89K |
| Asset deal income | 89.79%-221.83K | -24.12%-3.16M | -38.09%-2.1M | -518.97%-2.81M | -1,662.41%-2.17M | 46.88%-2.54M | 41.89%-1.52M | 79.20%-454.15K | 36.69%-123.26K | 40.07%-4.79M |
| Other revenue | -39.69%6.7M | -5.49%45.81M | 8.84%30.92M | 28.10%23.71M | 79.51%11.11M | 34.08%48.47M | 27.33%28.41M | 31.97%18.51M | 14.49%6.19M | 19.60%36.15M |
| Operating profit | 11.18%311.41M | -37.73%732.19M | -31.20%747.1M | -22.42%554.67M | -19.85%280.09M | 6.13%1.18B | 24.25%1.09B | 28.63%714.95M | 37.83%349.45M | 47.01%1.11B |
| Add:Non operating Income | 955.96%175.46K | -77.80%1.78M | -90.28%651.39K | -90.89%580.39K | -94.42%16.62K | 155.14%8.02M | 296.44%6.7M | 308.70%6.37M | 377.65%297.63K | 329.75%3.14M |
| Less:Non operating expense | 1,641.19%1.06M | 6.74%3.37M | -77.04%1.04M | -89.29%384.16K | -77.53%61.13K | -56.42%3.15M | 12.52%4.54M | 4.89%3.59M | -84.33%272.12K | -24.85%7.23M |
| Total profit | 10.88%310.52M | -38.12%730.6M | -31.37%746.71M | -22.69%554.87M | -19.87%280.04M | 6.96%1.18B | 24.83%1.09B | 29.57%717.73M | 38.76%349.48M | 48.22%1.1B |
| Less:Income tax cost | 38.19%60.62M | -17.24%123.53M | -7.89%113.86M | -17.73%79.26M | -37.35%43.87M | -18.36%149.27M | -4.99%123.61M | 12.25%96.33M | 57.39%70.02M | 65.34%182.85M |
| Net profit | 5.81%249.9M | -41.14%607.07M | -34.38%632.85M | -23.46%475.61M | -15.49%236.17M | 11.99%1.03B | 30.07%964.41M | 32.74%621.4M | 34.76%279.46M | 45.23%920.97M |
| Net profit from continuing operation | 5.81%249.9M | -41.14%607.07M | -34.38%632.85M | -23.46%475.61M | -15.49%236.17M | 11.99%1.03B | 30.07%964.41M | 32.74%621.4M | 34.76%279.46M | 45.23%920.97M |
| Less:Minority Profit | 48.01%-304.67K | 151.55%971.17K | 183.80%1.98M | 228.37%624.92K | 52.63%-585.99K | -856.79%-1.88M | -34.76%-2.36M | -817.53%-486.82K | -185.65%-1.24M | -178.76%-196.9K |
| Net profit of parent company owners | 5.68%250.2M | -41.34%606.1M | -34.74%630.88M | -23.62%474.99M | -15.65%236.76M | 12.17%1.03B | 30.08%966.77M | 32.86%621.89M | 35.07%280.69M | 45.32%921.17M |
| Earning per share | ||||||||||
| Basic earning per share | 7.69%0.28 | -41.38%0.68 | -35.78%0.7 | -24.29%0.53 | -18.75%0.26 | 4.50%1.16 | 21.11%1.09 | 25.00%0.7 | 28.00%0.32 | 44.16%1.11 |
| Diluted earning per share | 7.69%0.28 | -41.38%0.68 | -35.78%0.7 | -24.29%0.53 | -18.75%0.26 | 4.50%1.16 | 22.47%1.09 | 25.00%0.7 | 28.00%0.32 | 46.05%1.11 |
| Other composite income | 42.37%3.36M | 203.20%6.22M | -166.91%-3.87M | -72.14%1.71M | 66.70%2.36M | 120.82%2.05M | 74.41%5.79M | 1,292.04%6.14M | 257.72%1.42M | 190.25%929.42K |
| Other composite income of parent company owners | 42.37%3.36M | 203.20%6.22M | -166.91%-3.87M | -72.14%1.71M | 66.70%2.36M | 120.82%2.05M | 74.41%5.79M | 1,292.04%6.14M | 257.72%1.42M | 196.00%929.42K |
| Total composite income | 6.17%253.26M | -40.65%613.29M | -35.17%628.98M | -23.94%477.32M | -15.07%238.54M | 12.10%1.03B | 30.26%970.2M | 34.20%627.54M | 36.03%280.87M | 45.61%921.9M |
| Total composite income of parent company owners | 6.04%253.57M | -40.86%612.32M | -35.53%627.01M | -24.10%476.7M | -15.24%239.12M | 12.28%1.04B | 30.27%972.55M | 34.32%628.03M | 36.34%282.11M | 45.69%922.1M |
| Total composite income of minority owners | 48.01%-304.67K | 151.55%971.17K | 183.80%1.98M | 228.37%624.92K | 52.63%-585.99K | -856.79%-1.88M | -34.76%-2.36M | -817.53%-486.82K | -185.65%-1.24M | -204.59%-196.9K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.